Rare disease biotech Rezolute recently announced that the FDA has lifted the partial clinical hold on RZ358 (ersodetug), a ...

New data from the QWINT clinical trial may get Eli Lilly closer to bringing a once-weekly insulin injection to the US, ...

Clinical trials are becoming increasingly complex as emerging technologies such as immunotherapy enter the mainstream.

Adaptin Bio has announced that the FDA has given the green light to start phase 1 clinical trials for its program APTN-101 ...

The European Commission has granted Orphan Drug Designation for Vivet Therapeutics’ gene therapy product VTX-806 for the ...

Forge Biologics will help with the manufacturing of adeno-associated viruses (AAVs) in a collaboration with the non-profit ...

The San Diego-based biotech company Candid Therapeutics has launched with a huge $370 million with the aim to develop T-cell ...

Creyon Bio Inc., a clinical-stage biotechnology company specializing in AI and machine learning-enabled oligonucleotide-based ...

Beate Mueller-Tiemann is chief technology officer at Cytiva. With a passion for science and an ‘eternal technology optimist’, ...

Emmanuelle Cameau is strategic technology partnership leader at Cytiva. Read our interview to discover how losing her beloved ...

Valneva and Pfizer have reported positive Phase II results for a second booster dose of their vaccine candidate for Lyme ...

Eli Lilly will work with RNA-focused Haya Therapeutics to search for new targets to develop drugs for metabolic conditions ...